Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Acta Vascular Systems is a medical technology company dedicated to improving outcomes in catheter-based vascular procedures. The company specializes in the development of innovative vascular access and closure technologies, specifically targeting the challenges associated with large-bore arterial access. Its flagship product, the Acta Closure System, is designed to provide a secure and effective mechanical closure for femoral artery access sites following complex interventions like TAVR and EVAR. By streamlining the closure process and reducing the risk of vascular complications, Acta Vascular Systems aims to enhance patient safety and procedural efficiency. The company is headquartered in Menlo Park, California, and is backed by several prominent venture capital firms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Acta Vascular Systems.